200,000+ products from a single source!
sales@angenechem.com
1477-68-5 | Phenol, 4-(2-aminoethyl)-2-methoxy-, hydrochloride (1:1)
CAS No: 1477-68-5 Catalog No: AG001F40 MDL No:MFCD00012902
Product Description
Catalog Number:
AG001F40
Chemical Name:
Phenol, 4-(2-aminoethyl)-2-methoxy-, hydrochloride (1:1)
CAS Number:
1477-68-5
Molecular Formula:
C9H14ClNO2
Molecular Weight:
203.6660
MDL Number:
MFCD00012902
IUPAC Name:
4-(2-aminoethyl)-2-methoxyphenol;hydrochloride
InChI:
InChI=1S/C9H13NO2.ClH/c1-12-9-6-7(4-5-10)2-3-8(9)11;/h2-3,6,11H,4-5,10H2,1H3;1H
InChI Key:
AWRIOTVUTPLWLF-UHFFFAOYSA-N
SMILES:
NCCc1ccc(c(c1)OC)O.Cl
EC Number:
216-035-1
UNII:
95HIL684P5
NSC Number:
172190
Properties
Complexity:
130
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
2
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
203.071g/mol
Formal Charge:
0
Heavy Atom Count:
13
Hydrogen Bond Acceptor Count:
3
Hydrogen Bond Donor Count:
3
Isotope Atom Count:
0
Molecular Weight:
203.666g/mol
Monoisotopic Mass:
203.071g/mol
Rotatable Bond Count:
3
Topological Polar Surface Area:
55.5A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
Literature
| Title | Journal |
|---|---|
| Vitamin D signaling and the differentiation of developing dopamine systems. | Neuroscience 20161001 |
| Plasma methoxytyramine: a novel biomarker of metastatic pheochromocytoma and paraganglioma in relation to established risk factors of tumour size, location and SDHB mutation status. | European journal of cancer (Oxford, England : 1990) 20120701 |
| Ionic cross talk can lead to overestimation of 3-methoxytyramine during quantification of metanephrines by mass spectrometry. | Clinical chemistry 20120701 |
| Synthesis and evaluation of a set of para-substituted 4-phenylpiperidines and 4-phenylpiperazines as monoamine oxidase (MAO) inhibitors. | Journal of medicinal chemistry 20120412 |
| Comparative behavioral and neurochemical studies of R- and S-1-methyl-1,2,3,4-tetrahydroisoquinoline stereoisomers in the rat. | Pharmacological reports : PR 20120101 |
| Analysis of urinary neurotransmitters by capillary electrophoresis: sensitivity enhancement using field-amplified sample injection and molecular imprinted polymer solid phase extraction. | Analytica chimica acta 20110812 |
| Measurements of plasma methoxytyramine, normetanephrine, and metanephrine as discriminators of different hereditary forms of pheochromocytoma. | Clinical chemistry 20110301 |
| [Significance of 3-methoxytyramine urine measurement in the diagnosis of pheochromocytomas and paragangliomas: about 28 patients]. | Annales de biologie clinique 20110101 |
| Dopamine excess in patients with head and neck paragangliomas. | Anticancer research 20101201 |
| Modeling a sensitization stage and a precipitation stage for Parkinson's disease using prenatal and postnatal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration. | Neuroscience 20100901 |
| Binding of dopamine and 3-methoxytyramine as l-DOPA metabolites to human alpha(2)-adrenergic and dopaminergic receptors. | Neuroscience research 20100701 |
| Pilot quality assurance programme for plasma metanephrines. | Annals of clinical biochemistry 20100301 |
| Stereoselective effect of kynurenine enantiomers on the excretion of serotonin and its metabolite in rat urine. | Chirality 20100201 |
| Increased urinary excretion of 3-methoxytyramine in patients with head and neck paragangliomas. | The Journal of clinical endocrinology and metabolism 20100101 |
| The dopamine metabolite 3-methoxytyramine is a neuromodulator. | PloS one 20100101 |
| Important role of 3-methoxytyramine in the inhibition of cocaine sensitization by 1-methyl-1,2,3,4-tetrahydroisoquinoline: an in vivo microdialysis study. | Pharmacological reports : PR 20100101 |
| Dietary influences on plasma and urinary metanephrines: implications for diagnosis of catecholamine-producing tumors. | The Journal of clinical endocrinology and metabolism 20090801 |
| Direct injection horse-urine analysis for the quantification and confirmation of threshold substances for doping control. IV. Determination of 3-methoxytyramine by hydrophilic interaction liquid chromatography/quadrupole time-of-flight mass spectrometry. | Drug testing and analysis 20090801 |
| MPTP-induced model of Parkinson's disease in cytochrome P450 2E1 knockout mice. | Neuropharmacology 20090601 |
| Effect of estradiol on striatal dopamine activity of female hemiparkinsonian monkeys. | Journal of neuroscience research 20090515 |
| 3-Methoxytyramine, an extraneuronal dopamine metabolite plays a physiological role in the brain as an inhibitory regulator of catecholaminergic activity. | European journal of pharmacology 20081203 |
| Effects of cyclic hydrostatic pressure on the brain biogenic amines concentrations in the flounder, Platichthys flesus. | General and comparative endocrinology 20070101 |
| Fibroblast growth factor receptor signaling affects development and function of dopamine neurons - inhibition results in a schizophrenia-like syndrome in transgenic mice. | Journal of neurochemistry 20060601 |
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. | Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501 |
| Parkin suppresses the expression of monoamine oxidases. | The Journal of biological chemistry 20060331 |
| Use of tris(2,2'-bipyridine)osmium as a photoluminescence-following electron-transfer reagent for postcolumn detection in capillary high-performance liquid chromatography. | Analytical chemistry 20060315 |
| Variations of dopamine, serotonin, and amino acid concentrations in Noda epileptic rat (NER) retina. | Brain research 20060127 |
| Role of endogenous melatonin in the oxidative homeostasis of the extracellular striatal compartment: a microdialysis study in PC12 cells in vitro and in the striatum of freely moving rats. | Journal of pineal research 20051101 |
| Isoflurane anesthesia induces biphasic effect on dopamine release in the rat striatum. | Brain research bulletin 20051015 |
| Biochemical and clinical manifestations of dopamine-producing paragangliomas: utility of plasma methoxytyramine. | The Journal of clinical endocrinology and metabolism 20050401 |
| Influence of paraquat on dopaminergic transporter in the rat brain. | Pharmacological reports : PR 20050101 |
| 3-Methoxytyramine as an indicator of dopaminergic manipulation in the equine athlete. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20041105 |
| Inhibition of brain mitochondrial respiration by dopamine and its metabolites: implications for Parkinson's disease and catecholamine-associated diseases. | Journal of neurochemistry 20041101 |
| The role of noradrenergic and dopaminergic hyperactivity in the development of spontaneous recurrence of methamphetamine psychosis and susceptibility to episode recurrence. | Annals of the New York Academy of Sciences 20041001 |
| Progressive sensorimotor impairment is not associated with reduced dopamine and high energy phosphate donors in a model of ataxia-telangiectasia. | Journal of neurochemistry 20040301 |
| Effect of U and 137Cs chronic contamination on dopamine and serotonin metabolism in the central nervous system of the rat. | Canadian journal of physiology and pharmacology 20040201 |
| Role of the nitric oxide/cyclic GMP pathway and ascorbic acid in 3-morpholinosydnonimine (SIN-1)-induced increases in dopamine secretion from PC12 cells. A microdialysis in vitro study. | Neuroscience letters 20031215 |
| Histidine-decarboxylase knockout mice show deficient nonreinforced episodic object memory, improved negatively reinforced water-maze performance, and increased neo- and ventro-striatal dopamine turnover. | Learning & memory (Cold Spring Harbor, N.Y.) 20031101 |
| Role of the nitric oxide/cyclic GMP pathway and extracellular environment in the nitric oxide donor-induced increase in dopamine secretion from PC12 cells: a microdialysis in vitro study. | Journal of neurochemistry 20030901 |
| Halothane attenuated haloperidol and enhanced clozapine-induced dopamine release in the rat striatum. | Neurochemistry international 20030701 |
| 1-methyl-1,2,3,4-tetrahydroisoquinoline protects against rotenone-induced mortality and biochemical changes in rat brain. | European journal of pharmacology 20030418 |
| Neonatal ventral hippocampal damage modifies serum corticosterone and dopamine release responses to acute footshock in adult Sprague-Dawley rats. | Synapse (New York, N.Y.) 20030315 |
| An investigation of dopaminergic metabolites in the striatum and in the substantia nigra in vivo utilising radiolabelled L-DOPA and high performance liquid chromatography: a new approach in the search for transmitter metabolites. | Neuroscience 20030101 |
| The medial prefrontal cortex mediates 3-methoxytyramine-induced behavioural changes in rat. | European journal of pharmacology 20020503 |
| Behavioral activity and stereotypy in rats induced by L-DOPA metabolites: a possible role in the adverse effects of chronic L-DOPA treatment of Parkinson's disease. | Brain research 20020315 |
| Predictable stress promotes place preference and low mesoaccumbens dopamine response. | Physiology & behavior 20020201 |
| Evaluation of specific high-performance liquid-chromatographic determinations of urinary metanephrine and normetanephrine by comparison with isotope dilution mass spectrometry. | Annals of clinical biochemistry 20011101 |
| Susceptibility to subsequent episodes of spontaneous recurrence of methamphetamine psychosis. | Drug and alcohol dependence 20011001 |
| Betalains of Celosia argentea. | Phytochemistry 20010901 |
| Stereoselective effect of (R)- and (S)-1-methyl-1,2,3,4-tetrahydroisoquinolines on a mouse model of Parkinson's disease. | Brain research bulletin 20010901 |
| Biochemical and pathological study of endogenous 1-benzyl-1,2,3,4-tetrahydroisoquinoline-induced parkinsonism in the mouse. | Brain research 20010713 |
| Different action on dopamine catabolic pathways of two endogenous 1,2,3,4-tetrahydroisoquinolines with similar antidopaminergic properties. | Journal of neurochemistry 20010701 |
| Evaluation of specific high-performance liquid-chromatographic determinations of urinary adrenaline and noradrenaline by comparison with isotope dilution mass spectrometry. | Annals of clinical biochemistry 20010701 |
| Oxygen inhalation enhances striatal dopamine metabolism and monoamineoxidase enzyme inhibition prevents it: a microdialysis study. | European journal of pharmacology 20010622 |
| Opposite genotype-dependent mesocorticolimbic dopamine response to stress. | Neuroscience 20010101 |
| Effects of repeated morphine treatment on metabolism of cerebral dopamine and serotonin in alcohol-preferring AA and alcohol-avoiding ANA rats. | Alcohol and alcoholism (Oxford, Oxfordshire) 20010101 |
| Alterations of amino acids and monoamine metabolism in male Fmr1 knockout mice: a putative animal model of the human fragile X mental retardation syndrome. | Neural plasticity 20010101 |
| Methamphetamine-induced striatal dopamine release, behavior changes and neurotoxicity in BALB/c mice. | International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience 20001001 |
| Hydroxyl radical formation following methamphetamine administration to rats. | Pharmacology & toxicology 19990901 |
| Acute effects of beclamide on brain regional monoamine concentrations, their metabolites and radioligand binding studies. | The Journal of pharmacy and pharmacology 19910601 |
Related Products
Featured Products
© 2019 Angene International Limited. All rights Reserved.